New Nordic Healthbrands AB Logo

New Nordic Healthbrands AB

Develops and markets herbal supplements, dietary supplements, and personal care products.

NNH | ST

Overview

Corporate Details

ISIN(s):
SE0001838038
LEI:
213800JGTLNSKRD49G44
Country:
Sweden
Address:
SÖDRA FÖRSTADSGATAN 3, 211 43 MALMÖ

Description

New Nordic Healthbrands AB is a company that develops and markets herbal supplements, dietary supplements, and personal care products. The company's foundation is its specialized knowledge of medicinal plants and natural ingredients. It offers a portfolio of products aimed at satisfying specific health and beauty needs, including vitamins, minerals, and herbal remedies. Product innovation is supported by an extensive proprietary electronic database of botanical information. The company distributes its products to consumers globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all New Nordic Healthbrands AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for New Nordic Healthbrands AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for New Nordic Healthbrands AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-01-27 Karl Kristian Bergman Jensen Other Sell 4,000 106,480.00 SEK
2023-01-27 Karl Kristian Bergman Jensen Other Sell 3,000 79,860.00 SEK
2023-01-26 Karl Kristian Bergman Jensen Other Sell 4,000 105,200.00 SEK
2023-01-26 Karl Kristian Bergman Jensen Other Sell 2,500 65,750.00 SEK
2023-01-25 Karl Kristian Bergman Jensen Other Sell 5,000 125,250.00 SEK
2023-01-25 Karl Kristian Bergman Jensen Other Sell 2,500 64,675.00 SEK
2023-01-24 Karl Kristian Bergman Jensen Other Sell 2,500 63,850.00 SEK
2023-01-24 Karl Kristian Bergman Jensen Other Sell 2,000 51,260.00 SEK
2023-01-23 Karl Kristian Bergman Jensen Other Sell 2,500 66,750.00 SEK
2023-01-23 Karl Kristian Bergman Jensen Other Sell 2,000 53,400.00 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.